Trials / Completed
CompletedNCT03572426
Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 164 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.
Detailed description
Adults ages 18-80 will be recruited if they are diagnosed with bipolar disorder, major depression, or have no mood symptoms. The adults will undergo a diagnostic interview, the Mini International Neuropsychiatric Interview (MINI) for the diagnosis. The subjects will also complete the Adverse Childhood Events Scale to evaluate for a genetic x environmental interaction in detecting bipolar disorder at initial assessment. Genotyping will be done by SNaPshot genotyping method and genetic sample will be collected via buccal swab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | genotyping all subjects | genotyping using SNaPshot genotyping method. |
Timeline
- Start date
- 2018-06-13
- Primary completion
- 2019-04-04
- Completion
- 2019-04-04
- First posted
- 2018-06-28
- Last updated
- 2019-07-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03572426. Inclusion in this directory is not an endorsement.